Ensysce Biosciences reported earnings of -$ 4.52 per ENSC share on Nov 12, 2026, beating analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.15 |
| Earnings Per Share (Surprise) | -$ 4.52 (-$ 4.37) |
| Last Year's EPS | -$ 1.06 |
| EPS YoY Change |
Out of the last 39 earnings reporting periods, Ensysce Biosciences beat analysts’ expectations 9 times and fell short of expectations 13 time(s). Ensysce Biosciences reported earnings per share of -$ 4.52 in the last report falling to reach an estimated EPS of -$ 0.15 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.15 | -$ 4.52 | -$ 1.29 | |
| Aug 13, 2026 | -$ 0.20 | -$ 0.20 | -$ 0.79 | |
| May 15, 2026 | -$ 0.73 | -$ 0.52 | -$ 1.39 | |
| Mar 30, 2026 | -$ 1.26 | -$ 0.75 | -$ 2.90 | |
| Nov 14, 2025 | -$ 0.85 | -$ 1.29 | -$ 2.90 | |
| Aug 13, 2025 | -$ 1.02 | -$ 0.79 | $ 1.05 | |
| May 13, 2025 | -$ 3.02 | -$ 1.39 | -$ 3.30 | |
| Mar 19, 2025 | -$ 2.74 | -$ 2.90 | -$ 8.25 | |
| Mar 10, 2025 | -$ 2.74 | -$ 2.90 | -$ 8.25 | |
| Nov 12, 2024 | -$ 0.29 | $ 1.05 | -$ 16.94 | |
| Aug 14, 2024 | -$ 0.39 | -$ 3.30 | -$ 0.87 | |
| May 13, 2024 | -$ 5.85 | -$ 8.25 | -$ 14.69 | |
| May 10, 2024 | -$ 13.49 | -$ 8.25 | -$ 31.18 | |
| Mar 15, 2024 | -$ 12.89 | -$ 16.94 | -$ 2.74 | |
| Nov 9, 2023 | -$ 15.89 | -$ 0.87 | -$ 9.23 | |
| Aug 11, 2023 | -$ 27.80 | -$ 14.69 | -$ 8.64 | |
| May 15, 2023 | -$ 76.15 | -$ 31.18 | -$ 7.20 | |
| Mar 30, 2023 | -$ 0.03 | -$ 2.74 | -$ 16.20 | |
| Nov 14, 2022 | -$ 0.03 | -$ 9.23 | -$ 2,555.74 | |
| Aug 11, 2022 | -$ 7.56 | -$ 8.64 | -$ 215.98 |
Ensysce Biosciences’s stock was trading at $ 0.3601 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, ENSC’s price increased to $ 0.4184 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 4.52 | $ 0.3601 | $ 0.4184 | |
| Aug 13, 2026 | -$ 0.20 | $ 0.3987 | $ 0.3999 | |
| May 15, 2026 | -$ 0.52 | $ 0.2772 | $ 0.317 | |
| Mar 30, 2026 | -$ 0.75 | $ 0.5275 | $ 0.5385 | |
| Nov 14, 2025 | -$ 1.29 | $ 2.07 | $ 1.96 | |
| Aug 13, 2025 | -$ 0.79 | $ 2.09 | $ 2.06 | |
| May 13, 2025 | -$ 1.39 | $ 2.19 | $ 2.31 | |
| Mar 19, 2025 | -$ 2.90 | $ 3.88 | $ 3.56 | |
| Mar 10, 2025 | -$ 2.90 | $ 5.02 | $ 4.60 | |
| Nov 12, 2024 | $ 1.05 | $ 10.37 | $ 10.64 | |
| Aug 14, 2024 | -$ 3.30 | $ 6.14 | $ 5.90 | |
| May 13, 2024 | -$ 8.25 | $ 7.86 | $ 8.33 | |
| May 10, 2024 | -$ 8.25 | $ 8.12 | $ 8.78 | |
| Mar 15, 2024 | -$ 16.94 | $ 11.25 | $ 12.15 | |
| Nov 9, 2023 | -$ 0.87 | $ 13.65 | $ 12.00 | |
| Aug 11, 2023 | -$ 14.69 | $ 29.40 | $ 29.70 | |
| May 15, 2023 | -$ 31.18 | $ 47.25 | $ 44.55 | |
| Mar 30, 2023 | -$ 2.74 | $ 102.62 | $ 72.90 | |
| Nov 14, 2022 | -$ 9.23 | $ 347.40 | $ 388.80 | |
| Aug 11, 2022 | -$ 8.64 | $ 1,922.76 | $ 1,746.36 |
Ensysce Biosciences released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Ensysce Biosciences missed analysts’ expectations during the last earnings period by
